Author

J. Guenthoer

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:host-pathogen & immune response· 3 Organism:human· 3 Assay:proteomics· 3 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1

Frequent Co-Authors

F. Ruiz· 3 shared H. Y. Chu· 3 shared J. Overbaugh· 3 shared M. Lilly· 3 shared V. Chohan· 3 shared C. I. Stoddard· 2 shared D. M. Depierreux· 2 shared D. Ralph· 2 shared

Activity by Year

2019-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

F. Ruiz

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Delineating the functional activity of antibodies with cross-reactivity to SARS-CoV-2, SARS-CoV-1 and related sarbecoviruses

F. Ruiz, W. Foreman, M. Lilly, V. A. Baharani, D. M. Depierreux, V. Chohan, A. L. Taylor, J. Guenthoer, D. Ralph, F. A. Matsen, H. Y. Chu, P. D. Bieniasz, M. Cote, T. N. Starr, J. Overbaugh

This study identifies cross-reactive antibodies against SARS-CoV-2 and related sarbecoviruses that target conserved epitopes and show broad neutralization potential.

bioRxiv · Apr 24, 2024Immunology

The S2 subunit of spike encodes diverse targets for functional antibody responses to SARS-CoV-2

J. Guenthoer, M. E. Garrett, M. Lilly, D. M. Depierreux, F. Ruiz, M. Chi, C. I. Stoddard, V. Chohan, K. Sung, D. Ralph, H. Y. Chu, F. A. Matsen, J. Overbaugh

This paper identifies diverse functional antibodies targeting the S2 subunit of SARS-CoV-2 spike, including one with broad neutralization activity across multiple coronaviruses.

bioRxiv · Feb 26, 2024 · PreprintImmunology

Identification of broad, potent antibodies to functionally constrained regions of SARS-CoV-2 spike following a breakthrough infection

J. Guenthoer, M. Lilly, T. N. Starr, B. Dadonaite, K. N. Lovendahl, J. T. Croft, C. I. Stoddard, V. Chohan, S. Ding, F. Ruiz, M. S. Kopp, A. Finzi, J. D. Bloom, H. Y. Chu, K. K. Lee, J. Overbaugh

This study identifies four broad, potent monoclonal antibodies against SARS-CoV-2 spike protein that neutralize multiple variants, including Omicron and XBB.1.5, targeting conserved regions with high functional constraint.

bioRxiv · Dec 15, 2022 · PreprintImmunology

Molecular features of premenopausal breast cancers in Latin American women: pilot results from the PRECAMA study

M. Olivier, L. Bouaoun, S. Villar, A. Robitaille, V. Cahais, A. Heguy, G. Byrnes, F. Le Calvez-Kelm, G. Torres-Mejia, I. Alvarado-Cabrero, F. S. Imani-Razavi, G. Ines Sanchez, R. Jaramillo, C. Porras, A. C. Rodriguez, , S. Rinaldi

The paper characterizes molecular features of premenopausal breast cancers in Latin American women using genomic and immunohistochemical analyses, finding distinct mutational patterns in TP53 and exome-wide signatures compared to other populations.

PLOS ONE · Jan 17, 2019Peer-reviewedCancer Biology